
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Bergamot (Citrus bergamia) is rich in unique flavanone glycosides like neoeriocitrin, neohesperidin, naringin, brutieridin, and melitidin. These compounds primarily exert effects by inhibiting HMG-CoA reductase to lower cholesterol, activating SIRT1 via AMPK for anti-inflammatory responses, and boosting antioxidant enzymes.

Reported Benefits (Provisional)
Origin & History

Bergamot Pear, a varietal of *Pyrus communis* or *Citrus bergamia*, is native to the Mediterranean basin, particularly Italy, Greece, and North Africa. Thriving in subtropical climates, it is traditionally revered for its potent antioxidant, cardiovascular-supporting, and metabolic-regulating properties, making it a significant functional food.
Research Narrative (Provisional)
Emerging studies validate Bergamot Pear's lipid-lowering, antioxidant, and neuroprotective properties, supporting its role in metabolic health and cardiovascular integrity. Clinical literature recognizes its potential for systemic inflammation reduction. Continued research, including human clinical trials, will further elucidate its full therapeutic scope.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamin A (as Carotenoids), Vitamin C, Vitamin E - Minerals: Potassium, Magnesium, Calcium - Dietary Fiber: Prebiotic fibers - Phytochemicals: Flavonoids, Polyphenols, Citrus bioflavonoids, Bergamotins - Enzymes: Digestive enzymes
Reported Mechanism (Provisional)
Bergamot's unique flavanone glycosides, including naringin, brutieridin, and melitidin, primarily inhibit HMG-CoA reductase, a key enzyme in cholesterol synthesis, thereby reducing circulating lipid levels. Additionally, its bioactive compounds activate SIRT1 through AMPK, leading to anti-inflammatory effects, and enhance antioxidant enzymes like CAT and SOD, along with the pentose phosphate pathway (G6PDH), to combat oxidative stress and lipid peroxidation.
Clinical Narrative (Provisional)
Emerging clinical studies and in vitro/in vivo research support Bergamot's role in improving metabolic and cardiovascular health. Outcomes observed include significant reductions in LDL cholesterol and triglycerides, alongside increases in HDL cholesterol, in cohorts ranging from dozens to hundreds of participants. Additionally, research points to its antioxidant and anti-inflammatory benefits, with demonstrated potential for reducing systemic inflammation markers and enhancing neuroprotection. While promising, further large-scale human clinical trials are ongoing to fully elucidate its efficacy and optimal dosages across diverse populations.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







